Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Hsiang Lo

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Tumori|January 7, 2017
Stereotactic ablative radiotherapy for patients with unresectable or medically inoperable cholangiocarcinomaMing-Yueh Liu, Cheng-Hsiang Lo, Chun-Shu Lin, et al.
Plos One|April 7, 2017
Risk of second primary malignancies among patients with prostate cancer: A population-based cohort studyChao-Yueh Fan, Wen-Yen Huang, Chun-Shu Lin, et al.
Journal of Hepatocellular Carcinoma|November 12, 2021
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular CarcinomaChih-Weim Hsiang, Wen-Yen Huang, Jen-Fu Yang, et al.
Scientific Reports|November 9, 2022
Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinomaJen-Fu Yang, Wen-Yen Huang, Cheng-Hsiang Lo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Ming-Yueh Liu, Meei-Shyuan Lee, et al.
Plos One|March 23, 2017
Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancerWen-Yen Huang, Ching-Liang Ho, Chia-Cheng Lee, et al.
Medicine|March 18, 2016
Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential RadiotherapyJen-Fu Yang, Meei-Shyuan Lee, Chun-Shu Lin, et al.
Japanese Journal of Clinical Oncology|May 9, 2022
Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA dataPo-Chien Shen, Ying-Fu Wang, Hao-Chih Chang, et al.
Biomedicines|March 25, 2022
Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body RadiotherapyPo-Chien Shen, Wen-Yen Huang, Yang-Hong Dai, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Tumori|January 7, 2017
Stereotactic ablative radiotherapy for patients with unresectable or medically inoperable cholangiocarcinomaMing-Yueh Liu, Cheng-Hsiang Lo, Chun-Shu Lin, et al.
Plos One|April 7, 2017
Risk of second primary malignancies among patients with prostate cancer: A population-based cohort studyChao-Yueh Fan, Wen-Yen Huang, Chun-Shu Lin, et al.
Journal of Hepatocellular Carcinoma|November 12, 2021
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular CarcinomaChih-Weim Hsiang, Wen-Yen Huang, Jen-Fu Yang, et al.
Scientific Reports|November 9, 2022
Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinomaJen-Fu Yang, Wen-Yen Huang, Cheng-Hsiang Lo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Ming-Yueh Liu, Meei-Shyuan Lee, et al.
Plos One|March 23, 2017
Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancerWen-Yen Huang, Ching-Liang Ho, Chia-Cheng Lee, et al.
Medicine|March 18, 2016
Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential RadiotherapyJen-Fu Yang, Meei-Shyuan Lee, Chun-Shu Lin, et al.
Japanese Journal of Clinical Oncology|May 9, 2022
Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA dataPo-Chien Shen, Ying-Fu Wang, Hao-Chih Chang, et al.
Biomedicines|March 25, 2022
Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body RadiotherapyPo-Chien Shen, Wen-Yen Huang, Yang-Hong Dai, et al.
Pageof 4